Q1 EPS Estimates for Organigram Lowered by Analyst

Organigram Holdings Inc. (NASDAQ:OGI) – Equities researchers at Alliance Global Partners dropped their Q1 2025 earnings per share estimates for Organigram in a report released on Wednesday, December 18th. Alliance Global Partners analyst A. Grey now forecasts that the company will post earnings of ($0.04) per share for the quarter, down from their previous estimate of ($0.01). The consensus estimate for Organigram’s current full-year earnings is ($0.20) per share. Alliance Global Partners also issued estimates for Organigram’s Q2 2025 earnings at ($0.03) EPS, Q3 2025 earnings at ($0.03) EPS, Q4 2025 earnings at ($0.03) EPS, FY2025 earnings at ($0.11) EPS and FY2026 earnings at ($0.08) EPS.

Organigram Stock Down 1.3 %

OGI stock opened at $1.56 on Monday. The company has a 50-day simple moving average of $1.61 and a 200 day simple moving average of $1.67. The company has a market capitalization of $196.80 million, a P/E ratio of -3.71 and a beta of 1.02. Organigram has a fifty-two week low of $1.25 and a fifty-two week high of $2.91.

Organigram (NASDAQ:OGI) last announced its quarterly earnings results on Wednesday, December 18th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). Organigram had a negative return on equity of 16.76% and a negative net margin of 45.57%.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Tidal Investments LLC boosted its stake in Organigram by 8.3% during the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock valued at $3,526,000 after purchasing an additional 149,171 shares in the last quarter. AdvisorShares Investments LLC lifted its holdings in shares of Organigram by 11.8% in the second quarter. AdvisorShares Investments LLC now owns 1,000,126 shares of the company’s stock valued at $1,540,000 after buying an additional 105,468 shares during the period. Renaissance Technologies LLC boosted its stake in Organigram by 40.8% during the second quarter. Renaissance Technologies LLC now owns 816,948 shares of the company’s stock valued at $1,258,000 after buying an additional 236,700 shares in the last quarter. Finally, Toronto Dominion Bank grew its holdings in Organigram by 803.7% during the third quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock worth $30,000 after acquiring an additional 14,876 shares during the period. Institutional investors and hedge funds own 34.63% of the company’s stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.